Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
ID
iShares Genomics Immunology and Healthcare ETF
IDNA
Volume
202.99K
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
ID
IDNA
ID
iShares Genomics Immunology and Healthcare ETF
IDNA
News
·
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
AUM
N/A
Volume
202.99K
Yield
0.62%
Chart
Earnings
News
About
Dividends
Insider
Filings
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
Merck & Co. has agreed to acquire SpringWorks Therapeutics for around $4 billion, a 26% premium over SpringWorks' 20-day average price. The acquisition will boost Merck's revenue and expand its U.S. healthcare presence, particularly in rare tumor treatments.
Benzinga · Apr 28, 2025
Top Thematic ETF Ideas for 2024: AI & More
BlackRock's Jay Jacobs discusses best investing themes for 2024.
Zacks Investment Research · Jan 24, 2024
Top Thematic ETF Ideas for 2024: AI & More
BlackRock's Jay Jacobs discusses best investing themes for 2024.
Zacks Investment Research · Jan 22, 2024
Time to Buy Moderna-Heavy ETFs on Vaccine Optimism?
Shares of Moderna witnessed a significant increase of more than 13% on Jan 2, 2024, driven by Oppenheimer's decision to upgrade the stock to "outperform," as quoted on CNBC.
Zacks Investment Research · Jan 4, 2024
Top ETFs Tracking CRISPR Gene Editing
These exchange-traded funds track companies in this biotech space.
The Motley Fool · Jun 28, 2023
Will 2023 be the Year of Cathie Wood ETFs?
Cathie Wood, famous for the success of Ark Investment's winning products, had faced a miserable fate in 2022. Will her ETFs see success in 2023?
Zacks Investment Research · Jan 25, 2023
Moderna ETFs Rallying on COVID-19 Vaccine Booster Shot Update
Moderna has been rallying on the latest positive booster shot-related update.
Zacks Investment Research · Mar 30, 2022
Is ARK's Stellar Run Over? 5 ETF Themes to Follow Cathie Wood
Though Cathie Wood's Ark Investment's star products underperformed in 2021 and may continue to lag the broader market in 2022, Wood's fans may follow these ETF strategies to capitalize on her vision.
Zacks Investment Research · Dec 29, 2021
The Week On Wall Street: The S&P Rolls To Another New High
Sector rotation and rolling corrections continue, further complicating the investment backdrop. As the Fed starts to “taper”, no one can claim they were shocked. Read more here.
Seeking Alpha · Dec 11, 2021
‘Proceed with caution’: here's what Wall Street analysts see for the U.S. stock market in 2022
The recent spike in market volatility may herald a bumpier U.S. stock market in 2022, as investors come to grips with an inflection point in monetary policy in the pandemic.
MarketWatch · Dec 9, 2021
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
ID
IDNA
iShares Genomics Immunology and Healthcare ETF
Buy
Sell
Market
Limit
Soon
IDNA
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any IDNA yet.
Related Tickers
Earnings
Dividends
Last · Jun 15
Semi-annual
Amount
$0.13
Yield
0.69%
Annual
$0.28